Equity
€59,690 from €2.2m in 2010
Equity fell by 97% in 15 years.
DR. J.C. VRYGHEM, OOGHEELKUNDE
Lifetime
19 annual accounts with figures on one time axis, 27 filings since 1999peak €1.4m (2012)
€1.3m▲ 2.9%
lowest -€227,885 (2015)
€262,720▲ 10.7%
peak €2.2m (2010)
€59,690▼ 53.0%
€902,701▼ 9.9%
peak 13.5 FTE (2023)
12 FTE▲ 4.3%
Board4 names since 2020
3 directorsVryghem Jérôme and 2 others
Owners
Documentsfilings and deeds
30-06-202631 days before the deadline
2025abbreviated format
Dividend €150,000Equity from €126,970 to €59,690
Key points
from the 2025 annual accountsTurnover
≈ €1.2m estimated
The abbreviated format states no turnover.
Debts
€902,701 94% of the balance sheet
Suppliers 10%Taxes and wages 13%Other 77%
Of this, €896,997 falls due within a year.
Investments
€80,136 0.4 × depreciation
Green is investment, beige is depreciation.
Staff
14 employees on 31-12-2025
In 2025, 30 people joined and 28 left.
Position in the sector
6.2%
Lower solvency than 88% of companies in human health. Sector median 59.2% · 3,053 companies.
Checked score
91
Excellent
Financially stronger than 28% of small companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 1,080 companies (NACE 86, small).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025
08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025lowest value
09-2025: < 0.1%● unchanged vs 08-2025lowest value
10-2025: < 0.1%● unchanged vs 09-2025lowest value
11-2025: < 0.1%● unchanged vs 10-2025lowest value
12-2025: < 0.1%● unchanged vs 11-2025lowest value
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: 0.1%▲ +0.1 percentage points vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.1%● unchanged vs 07-2026
09-2026: 0.1%● unchanged vs 08-2026highest value
10-2026: 0.1%● unchanged vs 09-2026
11-2026: 0.1%● unchanged vs 10-2026
Financial strengthAverage
Score breakdown
raises risk
Equity €59,690 (6.2% of total assets)
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 0.43, cash €313,300
Figures for financial year 2025 (filed on 30-06-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 5% of them on solvency, 8% on liquidity, 98% on profitability and 2% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 496 companies had the same profile as DR. J.C. VRYGHEM, OOGHEELKUNDE has now. Each dot is one company, two years later.
95.6%
were still trading
3.2%
stopped another way
1.2%
went bankrupt
The bankruptcy probability of DR. J.C. VRYGHEM, OOGHEELKUNDE itself is lower: 0.1% within 12 months. It rests on far more data about DR. J.C. VRYGHEM, OOGHEELKUNDE than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 496 companies, not a prediction for DR. J.C. VRYGHEM, OOGHEELKUNDE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.43 (0.44 in 2024), below 1. Short-term debt is 93.2% and cash 32.6% of total assets. 93.8% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 11% of 3053 sector peers (2025).
NBB · sector comparisonPosition among 3053 sector peers
Solvency
better than 11%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
31 days early
2024
30 days early
2023
8 days early
2022
31 days early
2021
18 days late
2020
29 days early
2020
40 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 22 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 1 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Amendment of the articles
Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0463744825
Appointment: Signifeye NV (director)
Permanent representative: Kathieen Moens · General meeting of 19-12-2023 · Gazette deed
Appointment: EqirisNV (director)
Permanent representative: ErikMertens · General meeting of 13-08-2021 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DR. J.C. VRYGHEM, OOGHEELKUNDE Woluwe-Saint-Pierre | €1.0m | €1.3m | 6.2% | 12 |
| Centre Radiologique Privé du Tournaisis Tournai | €1.2m | €1.7m | 49.2% | 8.1 |
| Association des Médecins exercant au Groupe santé CHC Liège | €1.1m | €1.1m | 83.3% | 10.5 |
| MEDISCH CENTRUM GENK Genk | €1.0m | €0.9m | 7.0% | 12.5 |
| Centre de Santé du Namurois - Réseau Solidaris Namur | €1.6m | €1.0m | 56.1% | 15.5 |
| DERMPAT Ghent | €1.2m | €1.1m | 51.7% | 11.4 |
| Attentia Aviation Medical Zaventem | €1.0m | €1.0m | 40.4% | 6.4 |
These companies have the same main activity as DR. J.C. VRYGHEM, OOGHEELKUNDE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1m and €1.6m, founded between 1979 and 2011.
Official details
Source: KBO- Status
- Active since 06-07-1998Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Joint committee
- 330.04Health institutions and services · annual accounts 2025
- Establishment unit
- 2.231.360.3831150 Woluwe-Saint-Pierre, since 25-06-1998
- Financial year end
- 31 December
- Peppol
- Reachable since 15-12-2025
Annual accounts 2025
- €962,391▼ 14.7%
- Employeeson 31-12-2025
- 14▲ 16.7%
- Filing
- Filed on 30-06-2026, 31 days before the end of the filing period
Companies linked to DR. J.C. VRYGHEM, OOGHEELKUNDE
Parent and group
Insights on DR. J.C. VRYGHEM, OOGHEELKUNDE
DR. J.C. VRYGHEM, OOGHEELKUNDE files the abbreviated format. That format states no turnover. The gross margin rose from €752,111 in 2007 to €1.3m in 2025.
The balance sheet grew most from 2009 to 2011 through fixed assets.
EQIRIS holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR. J.C. VRYGHEM, OOGHEELKUNDE
- What is the company number of DR. J.C. VRYGHEM, OOGHEELKUNDE?
- The company number of DR. J.C. VRYGHEM, OOGHEELKUNDE is 0463.744.825. The VAT number is the same number with BE in front: BE 0463.744.825.
- Where is DR. J.C. VRYGHEM, OOGHEELKUNDE based?
- The registered office is at Sint-Michielslaan 12, 1150 Woluwe-Saint-Pierre.Company details
- What does DR. J.C. VRYGHEM, OOGHEELKUNDE do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DR. J.C. VRYGHEM, OOGHEELKUNDE?
- DR. J.C. VRYGHEM, OOGHEELKUNDE is a private limited company (BV).
- When was DR. J.C. VRYGHEM, OOGHEELKUNDE founded?
- DR. J.C. VRYGHEM, OOGHEELKUNDE was founded on 06-07-1998.
- Is DR. J.C. VRYGHEM, OOGHEELKUNDE still active?
- Yes, DR. J.C. VRYGHEM, OOGHEELKUNDE is an active enterprise in the KBO register.
- How many employees does DR. J.C. VRYGHEM, OOGHEELKUNDE have?
- DR. J.C. VRYGHEM, OOGHEELKUNDE had an average of 12 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does DR. J.C. VRYGHEM, OOGHEELKUNDE fall under?
- In its 2025 annual accounts, DR. J.C. VRYGHEM, OOGHEELKUNDE states joint committee 330.04 (Health institutions and services).
- What is the turnover of DR. J.C. VRYGHEM, OOGHEELKUNDE?
- The turnover in financial year 2025 is ≈ €1.2m. This figure is estimated from the gross margin of €1.3m and 63 comparable companies (NACE 86). It probably lies between €1.1m and €1.7m.
- Is DR. J.C. VRYGHEM, OOGHEELKUNDE profitable?
- In financial year 2025, DR. J.C. VRYGHEM, OOGHEELKUNDE made a profit of €262,720.
- Where can I find the annual accounts of DR. J.C. VRYGHEM, OOGHEELKUNDE?
- DR. J.C. VRYGHEM, OOGHEELKUNDE filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR. J.C. VRYGHEM, OOGHEELKUNDE due?
- DR. J.C. VRYGHEM, OOGHEELKUNDE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See the other companies in the same group.Signifeye · 12 companies
See how customers, suppliers and banks see your own company and what to improve first.